OMECARDIO trial: a randomized, double-blind, placebo-controlled study on the impact of omega-3 on inflammageing biomarkers and vascular stiffness in hypertensive and dyslipidemic patients
Event:
ESC Congress 2025
Topic:
Pharmacotherapy
Session:
Inflammation, immunity, and fibrosis
